Abiopharma

Exicure, Inc. Reports First Quarter 2025 Financial Results

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altimmune, Inc. - ALT

Rosen Law Firm Urges Sarepta Therapeutics, Inc. (NASDAQ: SRPT) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

RetinalGenix Technologies Contracts with LabCorp to Support DNA/GPS Platform for Advanced Genetic and Retinal Health Screening

Emily in Paris Season 5: Everything We Know So Far

Zentek Provides Regulatory Update on ZenGUARD™ Enhanced Air Filters

SRPT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead the Sarepta Class Action Lawsuit

INmune Bio, Inc. Announces Approximately $19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Croom Lawrence Joins Hemostemix with Revenue Share Agreement and VesCell.Health Launch

NanoVibronix Inc Notification (NAOV)